Lessons from immuno-oncology: a new era for cancer nanomedicine?
Nature Reviews Drug Discovery 16, 369 (2017).
doi:10.1038/nrd.2017.34
Authors: Wen Jiang, Hengfeng Yuan, Charles K. Chan, Christina A. von Roemeling, Zuoqin Yan, Irving L. Weissman & Betty Y. S. Kim
Despite a decade of intensive preclinical research, the translation of cancer nanomedicine to the clinic has been slow. Here, we discuss how recent lessons learned from the successes with immuno-oncology therapies could be applied to cancer nanomedicine and how this may help to overcome some
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Wen Jiang Hengfeng Yuan Charles K. Chan Christina A. von Roemeling Zuoqin Yan Irving L. Weissman Betty Y. S. Kim Tags: Comment Source Type: research